🔹 Recurrent Pregnancy Loss (RPL) – Screening Recommendations

Experiencing multiple miscarriages can be emotionally and physically overwhelming. Our team provides comprehensive screening and evaluation to identify underlying causes and guide your journey toward a successful pregnancy.
Common Screening and Diagnostic Tests Include:

• Genetic Testing
  Evaluation of both partners through karyotype analysis to identify potential chromosomal abnormalities. Genetic testing of pregnancy tissue (when available) may also be recommended.
  
• Uterine Anatomy Assessment
  Imaging techniques like transvaginal ultrasound, saline infusion sonogram (SIS), or hysteroscopy help detect structural issues such as uterine septum, fibroids, or adhesions.
  
• Hormonal & Metabolic Evaluation
  Testing for thyroid function (TSH), prolactin levels, and blood sugar (HbA1c) to ensure hormonal balance and metabolic health.
  
• Immune and Clotting Disorders
  Screening for antiphospholipid antibody syndrome (APS) and selected thrombophilias to rule out blood clotting disorders that may affect pregnancy viability.
  
• Additional Testing
  Based on clinical history, tests may also be recommended for infections, autoimmune conditions, or endocrine disorders.
  

Early and thorough evaluation can dramatically improve the chances of a healthy pregnancy. Our approach is tailored, compassionate, and backed by the latest advancements in reproductive care.

Cervical Cancer Screening

​Cervical cancer is highly preventable and treatable when detected early. We follow nationally recognized screening guidelines to protect and empower women at every stage of life.
Recommended Screening Schedule:

• Ages 21–29:
  Routine Pap smear every 3 years
  
• Ages 30–65:
  Choose one of the following options:
  • Pap smear + HPV test (co-testing) every 5 years
  • Pap smear alone every 3 years
  • HPV test alone every 5 years
  
• Over 65:
  Screening may be discontinued if prior tests were normal and risk remains low.
  

If you have a history of abnormal results or other risk factors, we may recommend more frequent monitoring and follow-up.
Why It Matters:

• Early detection through Pap and HPV testing saves lives.
  
• The HPV vaccine offers added protection and is recommended for eligible women up to age 45.